Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Caspofungin acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for caspofungin acetate and what is the scope of caspofungin acetate freedom to operate?

Caspofungin acetate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa and Merck, and is included in two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Caspofungin acetate has forty-nine patent family members in forty countries.

There are seven drug master file entries for caspofungin acetate. Two suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: caspofungin acetate

Tradenames:2
Patents:3
Applicants:2
NDAs:2
Drug Master File Entries: see list7
Suppliers / Packagers: see list2
Bulk Api Vendors: see list25
Clinical Trials: see list460
Patent Applications: see list509
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:caspofungin acetate at DailyMed

Pharmacology for Ingredient: caspofungin acetate

Ingredient-typeLipopeptides
Drug ClassEchinocandin Antifungal

Tentative approvals for CASPOFUNGIN ACETATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe50MG/VIALINJECTABLE; INJECTION
► Subscribe► Subscribe70MG/VIALINJECTABLE; INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
CANCIDAS
caspofungin acetate
POWDER;IV (INFUSION)021227-002Jan 26, 2001APRXYesYes5,952,300*PED► SubscribeY► Subscribe
Merck
CANCIDAS
caspofungin acetate
POWDER;IV (INFUSION)021227-001Jan 26, 2001APRXYesYes5,952,300*PED► SubscribeY► Subscribe
Fresenius Kabi Usa
CASPOFUNGIN ACETATE
caspofungin acetate
POWDER;IV (INFUSION)206110-001Dec 30, 2016APRXNoNo► Subscribe► Subscribe
Merck
CANCIDAS
caspofungin acetate
POWDER;IV (INFUSION)021227-001Jan 26, 2001APRXYesYes6,136,783*PED► SubscribeY► Subscribe
Merck
CANCIDAS
caspofungin acetate
POWDER;IV (INFUSION)021227-002Jan 26, 2001APRXYesYes6,136,783*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot